Karen Flynn's Trading History
| STVNStevanato Group | Jun 26, 2026 | Director | Uninformative Buy | ― | $111.57K | |
| SHCSotera Health | May 27, 2026 | Director | Uninformative Buy | ― | $983.57K | |
| QTRXQuanterix | Jan 06, 2026 | Director | Uninformative Buy | ― | $166.20K | |
| CTLTCatalent | Oct 31, 2023 | ― | Uninformative Buy | ― | $1.55M | |
| SCTLSocietal CDMO | Dec 16, 2019 | ― | Uninformative Buy | ― | $43.21K | |
| WSTWest Pharmaceutical Services | Feb 21, 2019 | Sr VP & Chief Commercial Offic | Uninformative Buy | 215.17K | $9.78M |
You May Also Like
Karen Flynn insider profile FAQ
What is the percentage of profitable transactions made by Karen Flynn?
The percentage of profitable transactions made by Karen Flynn is 14%.
What is the average return per transaction made by Karen Flynn?
The average return per transaction made by Karen Flynn is -14.30%.
What stocks does Karen Flynn hold?
Karen Flynn holds: STVN, WST, CTLT, QTRX, SHC, SCTL stocks.
What was Karen Flynn's most profitable transaction?
Karen Flynn’s most profitable transaction was an Informative Buy of SCTL stock on December 19, 2016. The return on the trade was 36.70%.
What is Karen Flynn's role in Stevanato Group?
Karen Flynn's role in Stevanato Group is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.